DRREDDY

SUNPHARMA

and other pharma stocks corrected as Trump threatens 25% tariff on India

Indian pharma stocks fell after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns rose about potential inclusion of generic drugs in the tariff list. Analysts expect strategic shifts by exporters and a cautious, range-bound market reaction.